Causes of Kinesiophobia in Lymphedema

Lymphedema Clinical Trial

Official title:

Investigation of Causes of Kinesiophobia, Fatigue and Quality of Life in Patients With Lower Extremity Lymphedema

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05105594
• Other study ID #: CSP1
• Status: Enrolling by invitation
• Phase: N/A
• Start date: November 15, 2021
• Est. completion date: December 15, 2021

Study information

• Verified date: November 2021
• Source: Ankara City Hospital Bilkent
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, the reason for the fear of movement in patients with lymphedema will be investigated and recommendations will be given to the patients to eliminate it.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 90
• Est. completion date: December 15, 2021
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Those between the ages of 18-65

• To be diagnosed with lymphedema in the unilateral lower extremity

• Volunteering to work

• Not having orthopedic disorders in the lower extremities

Exclusion Criteria:

• Not volunteering to participate in the research

• Having bilateral lower extremity lymphedema

• Having an active infection

• Having a mental cognitive disorder

• Being unable to communicate and cooperate

Related Conditions & MeSH terms

• Lymphedema

Intervention

Other:
• survey application
Fear of movement will be evaluated with the Kinesiophopia Causes Scale. It is a 20-question survey in which the causes of fear of movement are investigated. Functional Evaluation of Treatment of Fatigue Chronic Disease will be assessed by the Fatigue Questionnaire. It consists of 13 questions assessing the level of fatigue during daily activities in the last 7 days. Quality of Life will be assessed by the Lymphedema Quality of Life Questionnaire.

Locations

Country	Name	City	State
Turkey	Ankara City Hospital	Ankara	Çankaya

Sponsors (1)

Lead Sponsor	Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Kinesiophopia Causes Scale	It is a 20 question survey. A higher score on the questionnaire indicates that they have more fear of movement.	10 minutes
Primary	functional assessment of chronic illness therapy	It consists of 13 questions assessing the level of fatigue during daily activities in the last 7 days.	10 minutes
Primary	Lymphedema Quality of Life Questionnaire	It is a survey consisting of 21 questions. High scores indicate lower quality of life.	10 minutes